Back to RA CAPITAL MANAGEMENT, L.P. RA CAPITAL MANAGEMENT, L.P.

NAMSNAMS
15 quarters

Position history for RA CAPITAL MANAGEMENT, L.P.RA CAPITAL MANAGEMENT, L.P.'s holdings in NewAmsterdam Pharma Company N.V.

RA CAPITAL MANAGEMENT, L.P. holds 9.6M shares of NAMS (NewAmsterdam Pharma Company N.V.), worth $323.7M as of 2026-Q2. NAMS represents 2.8% of RA CAPITAL MANAGEMENT, L.P.'s portfolio.

Current Value

$323.7M

Current Shares

9.6M

Total Value Change

+$280.1M

Total Shares Change

+5.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
9.6M
0.0%
$323.7M2.8%$33.89
0
2026-Q1
Unchanged
9.6M
0.0%
$305.7M3.2%$30.41
0
2025-Q4
Decreased
9.6M
-5.8%
$335M3.4%$34.74
0
2025-Q3
Unchanged
10.1M
0.0%
$288.4M3.6%$27.52
0
2025-Q2
Unchanged
10.1M
0.0%
$183.6M3.1%$18.57
0
2025-Q1
Increased
10.1M
+14.6%
$207.5M3.5%$21.76
64
2024-Q4
Increased
8.8M
+9.7%
$227.3M3.0%$25.60
62
2024-Q3
Unchanged
8.1M
0.0%
$133.9M1.5%$16.23
0
2024-Q2
Increased
8.1M
+2.5%
$154.9M2.0%$19.21
53
2024-Q1
Unchanged
7.9M
0.0%
$186M2.4%$23.65
0
2023-Q4
Decreased
7.9M
-12.6%
$87.8M1.4%$11.17
0
2023-Q3
Unchanged
9M
0.0%
$83.3M1.6%$9.25
0
2023-Q2
Increased
9M
+125.0%
$107M2.0%$12.12
83
2023-Q1
Unchanged
4M
0.0%
$53M1.2%$13.25
0
2022-Q4
New
4M
-
$43.6M0.9%$10.90
57

Other major holders of NAMS: Capital World Investors, FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used